RADIOLOGICAL SOCIETY OF NORTH AMERICA IMAGE: Noncalcified coronary plaque in an asymptomatic 52-year-old man living with HIV with a 10-year Framingham risk of 5%. Images show 256-section contrast-enhanced coronary CT angiography with electrocardiographic gating and curve reformat. A, B, CT scan shows a smooth noncalcified plaque in the right coronary artery (arrows) with 70%-80% stenosis....
A fungal disease diagnostic and educational programme has had a transformational impact on the mortality of HIV patients in Guatemala, according to new research. And the programme, say scientists at the Asociación de Salud Integral (ASI) in Guatemala City and The University of Manchester, will save lives in countries across the developing world if implemented. Image credit: University...
by Johns Hopkins University Bloomberg School of Public Health Pre-Exposure Prophylaxis (PrEP)- Single pills (brand name Truvada) containing two antiretroviral drugs, emtricitabine and tenofovir disoproxyl fumarate. Truvada is used for pre-exposure prophylaxis, or PrEP, a strategy in which healthy people routinely take antiretrovirals to reduce the risk of becoming infected with HIV. Credit: NIAID A study...
INSTITUT NATIONAL DE LA RECHERCHE SCIENTIFIQUE – INRS IMAGE: INRS PROFESSOR JULIEN VAN GREVENYNGHE, EXPERT IN IMMUNOLOGY AND VIROLOGY, AND DOCTORAL STUDENT HAMZA LOUCIF, FIRST AUTHOR OF THE PAPER. CREDIT: INRS Prompted by the need to improve conventional treatments for people infected with the human immunodeficiency virus (HIV-1), a team from the Institut national de la...
by Washington University School of Medicine HIV-1 Virus. Credit: J Roberto Trujillo/Wikipedia Treatment for HIV has improved tremendously over the past 30 years; once a death sentence, the disease is now a manageable lifelong condition in many parts of the world. Life expectancy is about the same as that of individuals without HIV, though patients must...
by University of Pittsburgh Endowed Chair for Global Elimination of HIV and AIDS, and chief of the Division of Infectious Diseases at Pitt and UPMC. Increasingly, UPMC’s chief of infectious diseases—a well-regarded expert in HIV/AIDS—is contacted by a perplexed physician describing a patient with HIV who insists they are adhering to the daily medication regimen meant...
On January 10, Chinese researchers posted the novel coronavirus’ RNA sequence on a preprint server. Immediately, scientists who study genetic vaccines turned their efforts to the emerging pathogen that causes coronavirus disease 2019 (COVID-19). They knew that rapid response genetic platforms could shave precious weeks to months off development, crucial during a pandemic. They were...
n January 10, Chinese researchers posted the novel coronavirus’ RNA sequence on a preprint server. Immediately, scientists who study genetic vaccines turned their efforts to the emerging pathogen that causes coronavirus disease 2019 (COVID-19). They knew that rapid response genetic platforms could shave precious weeks to months off development, crucial during a pandemic.\ They were...
by Institute for Research in Biomedicine – IRB Hypermutation is an unusual occurence that can lead to many nearby mutations at once, severely damaging our genetic material and potentially causing cancer. The best known type of local hypermutation, called a mutation shower or thunderstorm, is quite uncommon and it leads to many mutations accumulated in...
A new drug regimen requiring injections every eight weeks have shown to be more effective in preventing HIV infection than one in which a pill must be taken daily, researchers from the HIV Prevention Trials Network (HPTN) announced at the 23rd International AIDS Conference. Emory University was a key participant in the study, enrolling seven...
